M&A Deal Summary

Nuwellis Acquires Rendiatech

On August 19, 2025, Nuwellis acquired medical products company Rendiatech

Acquisition Highlights
  • This is Nuwellis’ 1st transaction in the Medical Products sector.
  • This is Nuwellis’ 1st transaction in Israel.

M&A Deal Summary

Date 2025-08-19
Target Rendiatech
Sector Medical Products
Buyer(s) Nuwellis
Deal Type Add-on Acquisition

Target

Rendiatech

Israel
Rendiatech is a medical device company specializing in real-time urine flow and acute kidney injury monitoring technologies. The company’s key product, Rendiatech’s Clarity RMS, an FDA-cleared critical care monitoring system that continuously measures urine flow and automatically sends data and alerts of fluctuations to medical staff in real-time and its next-generation system.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Nuwellis

Eden Prairie, Minnesota, United States

Category Company
Founded 1999
Sector Medical Products
Employees70
Revenue 9M USD (2024)
DESCRIPTION

Nuwellis is an early-stage medical device company focused on developing, manufacturing and commercializing the C-Pulse System for treatment of Class III and ambulatory Class IV heart failure. Nuwellis was founded in 1999 and is based in Eden Prairie, Minnesota.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Israel M&A 1 of 1
Year: 2025 M&A 1 of 1